Nourin-Dependent miR-137 and miR-106b: Novel Biomarkers for Early Diagnosis of Myocardial Ischemia in Coronary Artery Disease Patients
暂无分享,去创建一个
M. Ibrahim | R. Christenson | D. Kreutzer | H. Kandil | Nashwa El-Khazragy | L. Rashed | S. A. Elgebaly | H. Rizk | S. Elgebaly | Heba Eldeeb | Beshoy Yacoub | Mahmoud Ali | B. Yacoub
[1] R. Christenson,et al. Nourin-Associated miRNAs: Novel Inflammatory Monitoring Markers for Cyclocreatine Phosphate Therapy in Heart Failure , 2021, International journal of molecular sciences.
[2] R. Christenson,et al. Nourin-Dependent miR-137 and miR-106b: Novel Early Inflammatory Diagnostic Biomarkers for Unstable Angina Patients , 2021, Biomolecules.
[3] Yao Chen,et al. Circulating Exosomal miRNAs as Novel Biomarkers for Stable Coronary Artery Disease , 2020, BioMed research international.
[4] R. Christenson,et al. Abstract 13051: Nourin-dependent Mirna-137 : A Novel Early Diagnostic Biomarker for Unstable Angina Patients , 2020 .
[5] R. Poston,et al. Abstract 13311: Cyclocreatine Phosphate: A Novel Mechanism for Preventing Development of Heart Failure , 2020 .
[6] R. Christenson,et al. Abstract 13103: Nourin-dependent Mirna-106b : A Novel Early Inflammatory Diagnostic Biomarker for Cardiac Injury , 2020 .
[7] V. Sreenivas,et al. Circulating miR-133b and miR-21: potential non-invasive diagnostic biomarkers of coronary artery disease , 2020 .
[8] Deepak L. Bhatt,et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. , 2020, European heart journal.
[9] V. Dilsizian,et al. Impact of the ISCHEMIA Trial on Stress Nuclear Myocardial Perfusion Imaging , 2020, The Journal of Nuclear Medicine.
[10] J. Ruidavets,et al. Identification of a miRNA Based-Signature Associated with Acute Coronary Syndrome: Evidence from the FLORINF Study , 2020, Journal of clinical medicine.
[11] E. Creemers,et al. MiR-223-3p and miR-122-5p as circulating biomarkers for plaque instability , 2020, Open Heart.
[12] E. Giannitsis,et al. Biomarkers for infarct diagnosis and rapid rule-out/rule-in of acute myocardial infarction , 2020, Herz.
[13] Lijie Wang,et al. Noncoding RNAs as Biomarkers for Acute Coronary Syndrome , 2020, BioMed research international.
[14] A. Kossaify,et al. Stress Echocardiography: Concept and Criteria, Structure and Steps, Obstacles and Outcomes, Focused Update and Review , 2020, Cardiology research.
[15] G. Lip,et al. Diagnosis and risk stratification of chest pain patients in the emergency department: focus on acute coronary syndromes. A position paper of the Acute Cardiovascular Care Association , 2020, European heart journal. Acute cardiovascular care.
[16] Ting Zhao,et al. MiR-137-3p exacerbates the ischemia-reperfusion injured cardiomyocyte apoptosis by targeting KLF15 , 2019, Naunyn-Schmiedeberg's Archives of Pharmacology.
[17] D. Stewart,et al. Systematic Review of MicroRNA Biomarkers in Acute Coronary Syndrome and Stable Coronary Artery Disease. , 2019, Cardiovascular research.
[18] R. Poston,et al. Cyclocreatine protects against ischemic injury and enhances cardiac recovery during early reperfusion , 2019, Expert review of cardiovascular therapy.
[19] B. Gersh,et al. Association Between Stress Testing–Induced Myocardial Ischemia and Clinical Events in Patients With Multivessel Coronary Artery Disease , 2019, JAMA internal medicine.
[20] G. Heusch. Myocardial ischemia: lack of coronary blood flow, myocardial oxygen supply-demand imbalance, or what? , 2019, American journal of physiology. Heart and circulatory physiology.
[21] H. Baynes,et al. Circulating microRNAs as possible biomarkers for coronary artery disease: a narrative review , 2019, EJIFCC.
[22] Xiaoping Zhou,et al. Diagnostic and prognostic value of biomarkers in acute myocardial infarction , 2019, Postgraduate Medical Journal.
[23] A. Jaffe,et al. High‐Sensitivity Cardiac Troponin After Cardiac Stress Test: A Systematic Review and Meta‐Analysis , 2019, Journal of the American Heart Association.
[24] I. Sahin,et al. Biomarkers in acute myocardial infarction: current perspectives , 2019, Vascular health and risk management.
[25] N. Tandon,et al. Assessment of asymptomatic ischemic heart disease using stress myocardial perfusion imaging in patients with type 2 diabetes mellitus , 2018, Indian heart journal.
[26] Peifeng Li,et al. Circulating miRNAs as biomarkers for early diagnosis of coronary artery disease , 2018, Expert opinion on therapeutic patents.
[27] D. Balanescu,et al. Limitations of Coronary Computed Tomography Angiography in Predicting Acute Coronary Syndrome in a Low to Intermediate-risk Patient with Chest Pain , 2018, Cureus.
[28] D. Berman,et al. Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) , 2018, Circulation. Cardiovascular quality and outcomes.
[29] Michael S Marber,et al. Cardiac troponins: from myocardial infarction to chronic disease , 2017, Cardiovascular research.
[30] N. Mills,et al. Cardiac Biomarkers and the Diagnosis of Myocardial Infarction in Women , 2017, Current Cardiology Reports.
[31] S. A. Elgebaly. Nourexal™: A Novel Anti-inflammatory / Antiapoptotic Therapy Against Reperfusion Injury , 2016 .
[32] G. Levine,et al. PCI Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease. , 2016, Journal of the American College of Cardiology.
[33] B. Gersh,et al. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. , 2016, European heart journal.
[34] Alejandro Lucia,et al. Epidemiology of coronary heart disease and acute coronary syndrome. , 2016, Annals of translational medicine.
[35] A. Arbab-Zadeh,et al. CARDIAC COMPUTED TOMOGRAPHY ( TC VILLINES , SECTION EDITOR ) Cardiac CT vs . Stress Testing in Patients with Suspected Coronary Artery Disease : Review and Expert Recommendations , 2015 .
[36] H. White,et al. High‐Sensitivity Cardiac Troponin T in Stable Patients Undergoing Pharmacological Stress Testing , 2015, Clinical cardiology.
[37] P. Douglas,et al. A Blood-Based Gene Expression Test for Obstructive Coronary Artery Disease Tested in Symptomatic Nondiabetic Patients Referred for Myocardial Perfusion Imaging The COMPASS Study , 2013, Circulation. Cardiovascular genetics.
[38] D. Berman,et al. Temporal trends in the frequency of inducible myocardial ischemia during cardiac stress testing: 1991 to 2009. , 2013, Journal of the American College of Cardiology.
[39] Ping Xie,et al. MiR-106b and MiR-15b Modulate Apoptosis and Angiogenesis in Myocardial Infarction , 2012, Cellular Physiology and Biochemistry.
[40] A. Arbab-Zadeh. Stress testing and non-invasive coronary angiography in patients with suspected coronary artery disease: time for a new paradigm , 2012, Heart international.
[41] Hyuk-Jae Chang,et al. Comparison of stress perfusion MRI and SPECT for detection of myocardial ischemia in patients with angiographically proven three-vessel coronary artery disease. , 2010, AJR. American journal of roentgenology.
[42] H. Katus,et al. Highly sensitive cardiac troponin T values remain constant after brief exercise- or pharmacologic-induced reversible myocardial ischemia. , 2008, Clinical chemistry.
[43] M. Sabatine,et al. Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35. , 2008, European heart journal.
[44] A. Jaffe,et al. Usefulness of detectable levels of troponin, below the 99th percentile of the normal range, as a clue to the presence of underlying coronary artery disease. , 2007, The American journal of cardiology.
[45] E. Picano,et al. Safety, feasibility, and prognostic implications of pharmacologic stress echocardiography in 1482 patients evaluated in an ambulatory setting. , 2001, American heart journal.
[46] S. Houser,et al. Cardiac-derived neutrophil chemotactic factors: detection in coronary sinus effluents of patients undergoing myocardial revascularization. , 1992, The Journal of thoracic and cardiovascular surgery.
[47] F. Forouhar,et al. Cardiac derived neutrophil chemotactic factors; preliminary biochemical characterization. , 1989, Journal of molecular and cellular cardiology.
[48] E. V. van Beek,et al. High-Sensitivity Cardiac Troponin I and the Diagnosis of Coronary Artery Disease in Patients With Suspected Angina Pectoris , 2018, Circulation. Cardiovascular quality and outcomes.
[49] A. Ibrahim,et al. Acute myocardial infarction. , 2014, Critical care clinics.